dc.contributor.author | Makwana, R | en_US |
dc.contributor.author | Sanger, GJ | en_US |
dc.date.accessioned | 2023-07-20T11:10:46Z | |
dc.date.available | 2023-07-07 | en_US |
dc.date.issued | 2023 | en_US |
dc.identifier.issn | 0014-2999 | en_US |
dc.identifier.other | ARTN 175906 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/89667 | |
dc.relation.ispartof | EUROPEAN JOURNAL OF PHARMACOLOGY | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | Stomach | en_US |
dc.subject | Oxytocin | en_US |
dc.subject | Vasopressin | en_US |
dc.subject | Interstitial cells of Cajal | en_US |
dc.subject | Rat | en_US |
dc.title | Characterization of rat gastric myogenic contractions and modulation by oxytocin and arginine-vasopressin | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1016/j.ejphar.2023.175906 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001044613000001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 955 | en_US |
qmul.funder | Drug design for disorders affecting gastrointestinal movements::Takeda Pharmaceuticals North America | en_US |